JMJD1A Antibodies

Santa Cruz Biotechnology delivers a wide array of JMJD1A monoclonal antibodies for research focused on understanding histone demethylase functions. JMJD1A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). JMJD1A, also known as Jumonji domain-containing protein 1A, is a histone demethylase that plays a critical role in the regulation of gene expression and chromatin remodeling. JMJD1A influences numerous cellular processes, including development, differentiation, and response to environmental stimuli. The proper functioning of JMJD1A is essential for maintaining cellular homeostasis and has implications in various diseases, including cancer. Researchers can explore JMJD1A's role in epigenetic regulation through detailed molecular studies. Advanced visualization techniques using specific conjugates such as horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) enable precise detection of JMJD1A in experimental settings. Understanding JMJD1A's involvement in chromatin modification pathways provides valuable insights into gene regulation mechanisms. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by enabling researchers to uncover new insights into JMJD1A's role in health and disease.